RxDoctor Payments DataLook up a doctor →

Mustafa Ahmed, MD

Cardiovascular Disease · Birmingham, ALNPI 1306093588

Payments from drug & device makers

$2,519,859in general payments, 2019–2025

Across 1,218 payments — averaging $2068.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1.1M
  • Medtronic$830K
  • Boston Scientific$397K
  • Philips North America LLC$72K
  • Edwards Lifesciences$52K
  • Inari Medical, Inc.$47K
  • plus $6K from 13 others

What the payments were for

  • Consulting fees$85,46039%
  • Speaking & faculty fees$82,22838%
  • Travel & lodging$33,22015%
  • Food & beverage$17,4938%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,519,859 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.

See all cardiovascular disease providers in Alabama

Medicare billing

Part B allowed, 2024
$736,651
Medicare patients
1,590
Services billed
6,271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$39,327
EntrestoSacubitril/Valsartan18$17,193
JardianceEmpagliflozin19$16,799
Repatha SureclickEvolocumab21$15,022
BrilintaTicagrelor13$5,517
Ranolazine ErRanolazine13$3,283
ClopidogrelClopidogrel Bisulfate63$856
Metoprolol Succinate39$584
Atorvastatin Calcium42$427
Potassium Chloride13$422
Isosorbide Mononitrate ErIsosorbide Mononitrate15$398
Furosemide34$134
Methylprednisolone16$123
Losartan Potassium11$115

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →